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Abstract: A key property of complex biological systems is the presence of interaction 
networks formed by its different components, primarily proteins. These are crucial for all 
levels of cellular function, including architecture, metabolism and signalling, as well as the 
availability of cellular energy. Very stable, but also rather transient and dynamic protein-
protein interactions generate new system properties at the level of multiprotein complexes, 
cellular compartments or the entire cell. Thus, interactomics is expected to largely 
contribute to emerging fields like systems biology or systems bioenergetics. The more 
recent technological development of high-throughput methods for interactomics research 
will dramatically increase our knowledge of protein interaction networks. The two most 
frequently used methods are yeast two-hybrid (Y2H) screening, a well established genetic 
in vivo approach, and affinity purification of complexes followed by mass spectrometry 
analysis, an emerging biochemical in vitro technique. So far, a majority of published 
interactions have been detected using an Y2H screen. However, with the massive 
application of this method, also some limitations have become apparent. This review 
provides an overview on available yeast two-hybrid methods, in particular focusing on 
more recent approaches. These allow detection of protein interactions in their native 
environment, as e.g. in the cytosol or bound to a membrane, by using cytosolic signalling 
cascades or split protein constructs. Strengths and weaknesses of these genetic methods are 
discussed and some guidelines for verification of detected protein-protein interactions   
are provided. 
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1. Interactomics Take Center Stage in Systems Biology 
1.1. A central role for protein interactions 
The field of systems biology has achieved tremendous momentum during recent years. This 
development has been driven by: (i) a huge amount of genomic and proteomic data already available, 
(ii) the need to understand complex cellular systems or multifactorial diseases such as cancer or the 
metabolic syndrome, and (iii) emerging technologies which allow high-throughput screening of 
complex mixtures of biomolecules or non-invasive studies of live cells or entire organisms. In 
addition, evolution in this field would have been impossible without the parallel development of 
bioinformatics tools to analyze the large amounts of data generated.  
Multiprotein complexes, not individual proteins, are increasingly recognized as the molecular basis 
of cellular fluxes of molecules, signals and energy. Thus, technologies which enable us to decipher 
cellular interactions between biomolecules (interactomics) together with those measuring metabolite 
fluxes (metabolomics, fluxomics) and signalling cascades (phosphoproteomics and others dealing with 
secondary protein modifications) have taken center stage in systems biology [1]. 
Interactomics can be applied in a global, unbiased cell systems approach, or in a more targeted 
approach to study a specific set of proteins [2]. While the former may identify so-called “nodes” or 
“hubs” in cell signalling but is often prone to errors (see discussion below on false negatives and 
positives), the latter is able to reliably describe sub-networks in more detail, including biophysical 
constants of the interaction and their spatiotemporal organization [3]. 
To date, the cellular interactome has mainly been explored for interactions involving proteins in the 
fields of cell signalling and cell architecture to understand the wiring of cellular data processing. 
However, it is also becoming increasingly important in many other fields.  
1.2. Systems bioenergetics 
Bioenergetics has known several decades of intense research, starting with the discovery of the 
main biochemical pathways and energy conservation in a chemiosmotic gradient in the 60s and 70s of 
the last century. After being a quiescent field for more than a decade, several developments during the 
last 15 years have put bioenergetics and mitochondria back to the forefront of scientific 
development [4] (for an excellent book see [5]): There has been the description of the involved protein 
machines at an atomic level (like the respiratory complexes in mitochondria), the discovery of a close 
link between mitochondria and cell signalling (calcium, apoptosis), and the emerging relationship 
between a dysfunction of cellular energetics and a plethora of complex pathologies, including   
(neuro-)muscular and age-related diseases, metabolic and cardiovascular diseases and cancer. 
Currently, the field of bioenergetics is about to enter the era of systems biology [6]. In fact, ATP 
generation needs a precise interplay between proteins of glycolysis, TCA cycle, mitochondrial electron Int. J. Mol. Sci. 2009, 10                 
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transport and energy transfer systems like creatine kinase, which often includes specific 
(micro)compartmentation of proteins or multiprotein complexes maintained by specific protein-protein 
interactions. These topologies then allow for more precise regulation or have further thermodynamic 
advantages like substrate channelling between active sites. Systems bioenergetics holds the promise of 
integrating the multiple aspects of cellular energetics in a holistic approach which: (i) extends our 
knowledge on protein complexes involved in metabolic control and cell signalling [7], (ii) considers 
cellular compartmentation particularly important in this field [8], and (iii) aims to understand the 
complex regulatory cellular network which governs homeostasis in cell energetics and which 
apparently fails in so many pathologies [9]. Inversely, manipulating energy metabolism holds promises 
for therapeutic strategies. For example, it was surprising that inhibiting mitochondrial complex I in 
mitochondria is part of the molecular mechanism of the most successful antidiabetic drug,   
metformin [10]. Thus, the emerging field of systems bioenergetics does not only involve basic 
research, but is of prime importance for applied and clinical scientists.  
For bioenergetics, interactomics goes far beyond cell signalling or cell structure, since it may 
uncover a new layer of regulation. The components of the mitochondrial redox chain or the ATPases 
are among the most complex protein assemblies, and understanding their regulation as well as the flux 
of protons and electrons will need intense work. Spatiotemporal organization of the long known 
pathways in primary metabolism is still incompletely understood [11], and the same applies to the 
systems of “energy-rich” intermediates like nucleoside triphosphates or phosphocreatine and 
mechanisms like metabolite channeling between different components in a complex [6,12,13]. 
1.3. Interactomics tools 
This review gives an overview of several methods for global or targeted interactomics, with a 
particular emphasis on classical and emerging yeast two-hybrid (Y2H) systems. These Y2H tools now 
allow access to the almost entire cellular proteome for interaction screening, including membrane 
proteins, transcriptionally active proteins and proteins localized in different subcellular compartments. 
Massive application of such tools can be expected, since they are comparatively inexpensive as 
compared to others, do not need specialized large equipment and can be performed in any molecular 
biology laboratory with reasonable throughput.  
2. Screening Technologies for Protein-Protein Interactions 
Protein-protein interactions are involved in all cellular processes. Mapping of these interaction 
networks to elucidate the organization of the proteome into functional units is thus of prime 
importance for systems biology. A large number of methods have been developed for screening protein 
interactions. The more classical biochemical approaches, such as copurification, affinity purification or 
coimmunoprecipitation of protein complexes require in vitro handling of protein extracts. Further 
limitations of these techniques include restricted sensitivity and bias towards high affinity interactions. 
Once a partner has been detected, identification by mass spectrometry (MS) is generally 
straightforward, although rather costly. Cloning of corresponding cDNAs may be time-consuming, but 
clone repositories such as RIKEN or IMACE can be a convenient alternative. More recently, surface 
plasmon resonance (SPR), a biophysical technology, has been adopted for screening protein-protein Int. J. Mol. Sci. 2009, 10                 
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interactions. Purified cellular extracts are injected onto a sensor chip covered with an immobilized 
binding partner. The instrument setup combines capture of the binding partner with a quantitative 
readout of the binding event, such that putative partners can be eluted and identified by MS [14,15]. 
Another approach to interaction screening are “cDNA-expression” libraries (for a review see [16]) 
such as phage display or Y2H methods, the latter detecting protein interactions in vivo. For studies on 
a genomic scale, highly parallel and automated processes are needed. However, only few detection 
methods for protein-protein interactions can be easily adapted for a high-throughput strategy. These 
include in particular yeast two-hybrid (Y2H) and affinity purification coupled to MS (AP/MS). 
2.1. Yeast two-hybrid 
The Y2H technique allows detection of interacting proteins in living yeast cells [17]. As described 
in full detail in chapter 3, interaction between two proteins, called bait and prey, activates reporter genes 
that enable growth on specific media or a color reaction. Y2H can be easily automated for high-
throughput studies of protein interactions on a genome-wide scale, as shown for viruses like 
bacteriophage T7 [18], Saccharomyces cerevisiae [19,20], Drosophila melanogaster [21], 
Caenorhabditis elegans [22] and humans [23,24]. Experimental Y2H data have been a crucial part in 
establishing large synthetic human interactomes [25,26] or to dissect mechanisms in human disease [27]. 
Two screening approaches can be distinguished: the matrix (or array) and the library approach.  
In the matrix approach, all possible combinations between full-length open reading frames (ORFs) 
are systematically examined by performing direct mating of a set of baits versus a set of preys 
expressed in different yeast mating types (e.g. mating type a for baits and mating type α for preys). 
This approach is easily automatable and has been used in yeast and human genome-scale two-hybrid 
screens. In yeast, 6,000 ORFs were cloned and over 5,600 interactions were identified, involving 70% 
of the yeast proteome [19,20,28]. The defined position of each bait in a matrix allows rapid 
identification of interacting preys without sequencing, but screens are usually restricted to a limited set 
of full length ORF’s and will thus fail to detect certain interactors (called false negatives).  
The classical cDNA-library screen searches for pairwise interactions between defined proteins of 
interest (bait) and their interaction partners (preys) present in cDNA libraries or sub-pools of libraries. 
An exhaustive screen of libraries with selected baits can be an alternative to a matrix approach. Here, 
preys are not separated on an array but pooled (reviewed in [29]), and libraries may contain cDNA 
fragments in addition to full length ORFs, thus largely covering a transcriptome and reducing the rate 
of false negatives. However, inherent to this type of library screening, the rate of wrongly identified 
proteins (called false positives) is increased. In addition, interaction partners have to be identified by 
colony PCR analysis and sequencing, making such screens more expensive and time consuming. 
2.2. Affinity purification/mass spectrometry 
The value of MS for high-throughput screening of protein interactions has been recognized only 
more recently. This analytical technique is based on the determination of the mass-to-charge ratio of 
ionized molecules. Already introduced in 1948, sensitivity and implementation range of MS has been 
largely extended by technological advances. These include Nobel prize crowned methods for 
ionization like electrospray ionization [30], generating ions from macromolecules in liquid medium Int. J. Mol. Sci. 2009, 10                 
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without their fragmentation, soft laser desorption (SLD) [31] or matrix-assisted laser 
desorption/ionization (MALDI) [32], using a laser beam for ionization of macromolecules without 
breaking chemical bonds. MS is now routinely applied to identify proteolytic fragments of proteins or 
even entire proteins and protein complexes [33]. Coupled to classic biochemical methods like affinity 
purification or chemical cross-linking, MS has become also a powerful tool for large-scale interactome 
research, mainly in form of affinity purification-MS (AP/MS). In this approach, a protein mostly fused 
to an epitope-tag is either immunoprecipitated by a specific antibody (e.g. against the tag) or purified 
by affinity columns recognizing the tag. Affinity purification can make use of an individual tag (e.g. a 
Flag-tag) for single step purification. However, it is more efficient when using two subsequent 
purification steps with proteins that are doubly tagged (e.g. 6xHis- and Strep-tag) or carry either C- or 
N-terminally a fusion of two affinity tags separated by a protease cleavage site (e.g. protein A and 
calmodulin binding protein) where the first tag is cleaved off after the first AP step (tandem affinity 
purification, TAP). This results in an enrichment of native multiprotein complexes containing the 
tagged protein. Subsequent MS analysis then identifies the different constituents of the 
complexes [34]. Ho et al. [35] expressed 10% of yeast ORFs with a C-terminal flag-tag under the 
control of an inducible promoter in yeast. They were able to connect 25% of the yeast proteome in a 
multiprotein complex interaction network. With the TAP-tag approach, Gavin et al. [36,37] and 
Krogan et al. [38] purified 1,993 and 2,357 TAP-fusion proteins covering 60% and 72% of the yeast 
proteome, respectively. As compared to the single Flag-tag approach, combination of two different 
purification steps in TAP results in improved sensitivity and specificity (TAP is reviewed in more 
detail in [39,40]). Recent technical progresses in automation of complex purification and MS analysis, 
together with dedicated computational methods to increase accuracy of data analysis, have made this 
approach a powerful tool in interactome research.  
2.3. Comparison of Y2H- and MS-based methods 
MS is less accessible than Y2H due to the expensive large equipment needed. Thus, a large amount 
of the data so far generated from protein interaction studies have come from Y2H screening. For 
example, more than 5,600 protein interactions have been so far reported for yeast [19,20,28,41] and 
about 6,000 for humans [23,24], establishing extensive protein interaction networks. Approximately 
half of the interaction data available on databases such as IntAct [42] and MINT [43] are coming from 
Y2H assays. Genome-scale Y2H screens have highlighted considerable cross-talk in the cell, even 
between proteins that were not thought to be functionally connected. However, Y2H and AP/MS are 
complementary in the kind of interactors that they are detecting. AP/MS may determine all the 
components of a larger complex, which not necessarily all interact directly with each other, while Y2H 
studies identify defined binary, interactions in this complex. In addition, some types of protein-protein 
interactions can be missed in Y2H due to inherent limitations, like interactions involving membrane 
proteins, self activating proteins, or proteins requiring post-translational modifications, but this may 
also occur with AP/MS-based approaches. Given the strengths of both methods, considerable effort is 
invested to overcome the remaining drawbacks. Different Y2H systems have been developed to extend 
the coverage of the proteome of interest, as will be described in detail further below. Recently, also the 
sensitivity and robustness of AP/MS was improved by the development of an integrated workflow Int. J. Mol. Sci. 2009, 10                 
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coupling rapid generation of bait-expressing cell lines with an increase in protein complex purification 
using a novel double-affinity strategy [44]. Only a combination of different approaches that necessarily 
includes bioinformatics tools, will eventually lead to a fairly complete characterization of 
physiologically relevant protein-protein interactions in a given cell or organism. This will be a 
fundamental requirement to use interactome data in a systems biology approach at the cellular or 
higher complexity level. 
3. Aiming at in Vivo Interactions: The Yeast Two-Hybrid Approach 
3.1. Historical perspective: The principles of the approach 
In 1989, Fields and Song revolutionized protein interaction analysis by describing a genetic system 
to detect direct protein-protein interactions in the yeast Saccharomyces cerevisiae [17]. Until then, 
interactions between two proteins had mostly been studied using biochemical techniques. The 
development of this completely new analytic tool was triggered by the molecular analysis of 
eukaryotic transcription factors. Only few years before, the Ptashne Laboratory had discovered the 
modular structure of Gal4, a transcriptional activator in yeast. They showed that Gal4 binds a specific 
DNA sequence (the upstream activation domain, UAS) and thus activates transcription in the presence 
of galactose. If separated into two fragments, the N-terminal fragment did still bind to DNA, but did 
not activate transcription in presence of galactose, while this latter function was mediated by the C-
terminal fragment [45]. However, both fragments could interact and non-covalently reconstitute a fully 
functional Gal4. Thus, two different functional domains of Gal4 were identified: an N-terminal DNA 
binding domain (DBD) and a C-terminal (transcriptional) activation domain (AD), with both 
individual domains maintaining their function independent of the presence of the other.  
Inspired by these findings, Fields and Song exploited the modular properties of the transcription 
factor Gal4 to monitor protein-protein interactions. The basic idea was to fuse the two proteins of 
interest X and Y to DBD and AD of Gal4, respectively, such that interaction between X and Y 
reconstitutes a functional transcription factor that could then drive reporter gene expression (Figure 1). 
In the first construct called bait, protein X (e.g. the glucose-sensor SNF1) was fused to the N-terminal 
part of GAL4 containing the DBD (GAL4DBD). In the second construct, the prey, protein Y (e.g. the 
regulatory protein SNF4) was fused to the C-terminal part of Gal4 that contains the AD (GAL4AD). 
Expression of both fusion proteins in yeast and interaction between bait and prey indeed reconstituted 
a functional Gal4 transcription factor from the two separate polypeptides. Gal4 then recruited RNA 
polymerase II, leading to transcription of a GAL1-lacZ fusion gene. This reporter gene encodes the 
enzyme beta-galactosidase which labels the yeast cell when using a colorimetric substrate [17].  
For a genome-wide screen for interactors of given baits, a cDNA library is used to construct an 
entire library of preys. From a methodological point of view, any such Y2H screen implies the 
transformation of yeast cells with bait and prey cDNA on different vectors under the control of yeast 
promoters. Expression levels will depend on the promoter used and may affect sensitivity and 
specificity of the screen. Once expressed in the cytosol, bait and prey must be able to enter the nucleus 
to activate transcription, a limitation of the original Y2H approach further discussed below. Int. J. Mol. Sci. 2009, 10                 
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Figure 1. The classical yeast two-hybrid system. (A) The protein of interest X, is fused to 
the DNA binding domain (DBD), a construct called bait. The potential interacting protein 
Y is fused to the activation domain (AD) and is called prey. (B) The bait, i.e. the DBD-X 
fusion protein, binds the upstream activator sequence (UAS) of the promoter. The 
interaction of bait with prey, i.e. the AD-Y fusion protein, recruits the AD and thus 
reconstitutes a functional transcription factor, leading to further recruitment of RNA 
polymerase II and subsequent transcription of a reporter gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This classical Y2H system has been extended to exploit different other DNA-binding proteins (e.g. 
DBD of E. coli repressor protein LexA), transcriptional activators (e.g. AD of Herpes simplex virus 
VP16) and various reporter genes. A suitable reporter gene must encode a protein whose function 
provides a simple readout. Thus, besides the colorimetric reaction with the lacZ gene, the most 
commonly used are auxotrophic markers (e.g. LEU2, HIS3, ADE2, URA3, LYS2) that allow growth on 
minimal media. In the current state-of-the-art, more than one reporter gene is assayed in parallel to 
increase the stringency of Y2H screens [46]. In fact, one of the common problems of Y2H is the 
generation of false positives due to non-specific interactions (as described in detail further below). 
Selection for two active reporter genes requires a more solid transcriptional activation and thus 
increases the stringency of the assay, but concomitantly penalizes detection of weak and transient 
interactions. Another possibility to adjust the stringency of the assay is partial inhibition of the 
enzymatic activity encoded by the reporter gene. For example, the product of the HIS3 reporter, 
imidazole glycerol phosphate dehydratase, is competitively inhibited by increasing concentrations of 
3-aminotriazole. Int. J. Mol. Sci. 2009, 10                 
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Table 1. Overview of different Y2H systems and their specificities. 
Year  Y2H method   Possible baits  Response  Cellular 
compartment * 
Screen 
compatibility 
# 
1989  Classic Y2H system 
 [17] 
Non-transactivating proteins 
capable of entering nucleus 
Transcriptional 
activation  Nucleus Yes  [17] 
1994  SOS recruitment system 
(SRS) [51] 
Transactivating, cytosolic 
proteins  Ras signalling   Membrane 
periphery   Yes [52] 
1994  Split-ubiquitin system    
[53]  
Nuclear, membrane and 
cytosolic proteins 
Uracil auxotrophy and 
5-FoA resistance  Cytosol Yes  [54] 
1998 
Membrane split-
ubiquitin system 
(MbY2H) [55] 
Membrane proteins  Transcriptional 
activation 
Membrane 
periphery   Yes [56] 
1998  Ras recruitment system 
(RRS) [57] 
Transactivating, cytosolic 
proteins  Ras signalling  Membrane 
periphery   Yes [57] 
1999  Dual bait system 
 [49] 
Two non-transactivating 
proteins capable of entering 
nucleus 
Transcriptional 
activation  Nucleus  Yes [49] 
2000  G-protein fusion system 
[58]  Membrane proteins  Inhibition of protein G 
signalling  
Membrane 
periphery  No 
2001 
RNA polymerase III 
based two-hybrid  
(Pol III) [59] 
Transactivating proteins  
(in the RNA polymerase II  
pathway ) 
Transcriptional 
activation  Nucleus  Yes [59] 
2001  Repressed transactivator 
system (RTA) [60] 
Transactivating proteins 
capable of entering nucleus 
Inhibition of 
transcriptional 
activation 
Nucleus Yes  [60-62] 
2001  Reverse Ras recruitment 
system (rRRS) [63]   Membrane proteins  Ras signalling  Membrane 
periphery   Yes [63] 
2003  SCINEX-P system 
 [64] 
Extracellular and 
transmembrane proteins 
Downstream signalling 
& transcriptional 
activation 
Endoplasmic 
reticulum (ER)  No 
2004  Split-Trp system 
 [65]  Cytosolic, membrane proteins  Trp1p activity  Cytosol 
Yes  
(Lentze & Auer-
bach, unpubl.) 
2007  Cytosolic split-ubiquitin 
system (cytoY2H) [66] 
Transactivating, cytosolic 
proteins 
Transcriptional 
activation 
ER membrane 
periphery  Yes [66] 
* Cellular compartment where the interaction occurs. 
# Indicates whether a given Y2H system has been used for cDNA-library screening. 
Compared to earlier interaction screens, the Y2H system was able to detect interactions in vivo in a 
true cellular environment. Since it is also relatively easy to implement and inexpensive, Y2H rapidly 
became the system of choice for detecting protein-protein interactions. Its principles were rapidly 
adopted for screenings involving interaction of more than two partners. To analyse ligand-receptor 
interactions, a synthetic heterodimer of two different small organic ligands is used as a third hybrid 
molecule together with two receptors fused to DBD and AD. In this case, binding of the hybrid organic 
ligand to both receptors will force them together to reconstitute the DBD-AD complex [47]. This three 
hybrid system can also be used to identify inhibitors of protein-protein interactions [48]. Another 
extension of the classical Y2H system is the use of more than one bait, in particular to compare 
interaction specificities [49]. In the so-called Dual Bait system, protein X1 is fused to the LexA DBD, 
and protein X2 is fused to the DBD of the cI repressor from bacteriophage λ. Thus, each bait is Int. J. Mol. Sci. 2009, 10                 
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directed to a different reporter gene. Positive interactions with X1 are registered through lexA operator 
activation of LEU2 and LacZ, and positive interactions with X2 through cI operator activation of LYS2 
and  GusA.  GusA codes for beta-glucuronidase that can use a colorimetric substrate to report 
interactions. This system has been successfully used to identify proteins interacting with specific 
regions in larger proteins [50]. Further more recent expansions of Y2H to high-throughput 
applications, the so-called matrix or array approach, has been already discussed in the   
previous chapter. 
In their original publication Fields and Song already mentioned some of the limits of their Y2H 
method: “The system requires that the interaction can occur within the yeast nucleus, that the Gal4-
activating region is accessible to the transcription machinery and that the Gal4(1-147)-protein X 
hybrid is itself not a potent activator”. These limitations would exclude almost half of all proteins, 
explaining the great interest for developing alternative Y2H variants. 
3.2. Choosing the right strategy: Available Y2H systems and their advantages 
More recent Y2H-based techniques access almost the entire cellular proteome (see Table 1). Almost 
all of them rely on a similar principle, namely the modular structure of the protein reporting the 
interaction. Similar to DBD and AD reconstituting a transcription factor in the original Y2H system, 
they employ proteins containing two structural domains which can fold correctly independently of 
each other and which reconstitute the functional reporter system if brought together via bait-prey 
interaction. An exception of this principle is the recruitment-based Y2H, where the reporter cascade is 
activated by forced membrane localization of the bait-prey complex. The following chapter will 
present in more detail the currently available Y2H systems (Table 1, Figure 2). 
 
3.2.1. Y2H with transactivating proteins in the nucleus 
 
The classic Y2H system is based on reconstitution of a transcription factor and thus not adapted for 
interaction analysis with proteins that can directly activate transcription. Such transactive baits would 
trigger transcription in absence of any interaction with a prey. Two alternative Y2H systems have been 
developed to analyze the interaction network of such proteins. One is based on repression of 
transactivation, while the other uses the alternative polymerase III transcription pathway.   
Also methods mentioned under 3.2.2 (e.g. the split-ubiquitin systems) are suitable to screen   
transactive baits. 
In the repressed transactivator (RTA) system (Figure 2A), inversely to the classic Y2H, the bait-
prey interaction represses transcriptional activation of reporter genes [60]. The protein of interest X 
fused to the DBD of Gal4 is transactive, e.g. a transcription factor. If it interacts with another protein Y 
fused to the repression domain (RD) of a transcription repressor (e.g. Tup1p), the transcription of the 
reporter gene is repressed [60]. The RTA system has been used to demonstrate interactions between 
the mammalian basic helix-loop-helix proteins MyoD and E12, and between the protooncogenic 
transcription factor c-Myc and the putative tumor suppressor protein Bin1 [60]. It has also been 
applied to screen for novel interactions with a variety of transcriptional activators, including herpes 
simplex virus 1 (HSV-1) regulatory protein VP16 [60], c-Myc [62], and the androgen receptor [61].  Int. J. Mol. Sci. 2009, 10                 
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Figure 2. Yeast two-hybrid systems, their subcellular location within a yeast cell, and their 
operating mode (represented at the moment of bait-prey interaction).  
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Figure 2. Cont. 
Protein X (dark blue puzzle piece, part of bait construct) and protein Y (light blue puzzle piece, part 
of prey construct) directly interact (fitting puzzle pieces), thus inducing reconstitution of split-
proteins (puzzle pieces of different colors in A, D, E), membrane recruitment (B, C) or protein 
dimerization (F). Protein fusions in bait or prey constructs are shown as solid black lines between 
puzzle pieces. Bait-prey interaction activates further downstream events (arrows) that directly (A) 
or indirectly (B, C, D, F) lead to transcriptional activation, or are independent of transcriptional 
activation (D, E), finally yielding screenable readouts like growth on specific media or color 
reactions. (A) Nuclear Y2H systems all require protein recruitment and bait-prey interaction at 
nuclear DNA. The classic Y2H and RTA Y2H both engage RNA polymerase II (RNA Pol II) 
transcription either by its activation or its inhibition. By contrast, the Pol III Y2H, involves RNA 
polymerase III (RNA Pol III) transcription. (B)  Ras signalling based Y2H at the plasma 
membrane. The SRS Y2H, RRS Y2H, and rRRS Y2H are all based on protein recruitment to the 
plasma membrane via bait-prey interaction and subsequent activation of MAPK downstream 
signalling. While in the SRS and RRS Y2H the prey constructs harboring protein Y are anchored at 
the membrane via myristoylation to analyze interactions with cytosolic bait constructs harboring 
protein X, the rRRS is used to analyze interactions between soluble preys containing protein Y and 
partner X being a membrane protein. (C) G-protein signalling-based Y2H at the plasma 
membrane. In the G-protein fusion Y2H, bait X is a membrane or membrane-associated protein 
whose interaction with the prey construct disrupts protein G downstream signalling. (D)  Split-
ubiquitin based Y2H systems involve reconstitution of ubiquitin from two domains upon bait-prey 
interaction. Their subcellular localization depends on the nature of interacting proteins X or Y, and 
on the reporter proteins used. The Split ubiquitin Y2H uses non-transcriptional reporting of protein 
interactions in the cytosol, but can also be used for membrane proteins (not shown). The MbY2H is 
used for interaction analysis with membrane baits and thus occurs at the membrane location of 
protein X, e.g. the plasma membrane. The CytoY2H is used for membrane anchored cytosolic baits 
and occurs close to the ER membrane (E) Split-protein sensor Y2H. The Split-Trp Y2H is used to 
assay cytosolic bait-prey interactions based on reconstitution of an enzyme in tryptophan synthesis, 
allowing for non-transcriptional reporting. (F) ER Y2H system. The SCINEX-P Y2H allows bait-
prey interaction analysis in the reducing environment of the ER, based on protein dimerization in 
unfolded protein signalling. ER, endoplasmic reticulum; for further abbreviations and details see 
chapter 3.2. 
 
Recently, this system has been extended to screen for molecules which inhibit protein-protein 
interaction, for example between the immunophilin FKBP12 and the transforming growth factor β 
receptor (TGFβ-R) C terminus [67]. FKBP12 itself is not transactivating, but was fused to VP16-AD 
in addition to Gal4-DBD. In the absence of interaction with a RD-fusion protein, e.g. due to the 
presence of an inhibitor, transcription of reporter gene HIS3 is activated. Strength of the inhibition is 
translated into expression levels of HIS3 which can be probed by increasing amounts of 3-
aminotriazole, a competitive inhibitor of the HIS3 gene product. Compared to the classic Y2H, this 
assay has the advantage that inhibition of interaction does not result in a loss but in a gain of reporter 
gene transcription and thus in a positive signal facilitating screening procedures. Thus, the RTA Y2H 
can not only be used to identify interaction partners of transcription factors, but also as a reversed Y2H 
to screen small molecule libraries e.g. for potentially novel therapeutic compounds acting as inhibitors 
of a given protein-protein interaction. Int. J. Mol. Sci. 2009, 10                 
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The RNA polymerase III based two-hybrid (Pol III) system (Figure 2A) is another alternative to 
screen for interaction partners of transcription factors activating RNA polymerase II-based 
transcription. As in the classic Y2H, a protein X is fused to a Gal4-DBD (bait), and this bait is able to 
bind DNA due to Gal4p binding sequence artificially introduced into the reporter gene SNR6. 
However, the prey construct is different, since the second protein Y is fused to τ138p. This protein is a 
subunit of the multimeric protein complex TFIIIC, one of the two transcription factors involved in 
RNA polymerase III (PolIII)-mediated transcription. If now the bait interacts with the prey containing 
τ138p, the TFIIIC complex is bound to DNA and recruits a second transcription factor (TFIIIB) and 
Pol III. This will activate transcription of the SNR6 reporter gene to produce U6 snRNA [68]. In a 
yeast strain harboring a temperature-sensitive U6 snRNA mutant [59], this reporter gene transcription 
will rescue the temperature-sensitive phenotype and allow yeast growth at 37°C. The system has been 
used to screen a mouse embryonic cDNA library using τ138p-mBRCA1 as a bait [59], but apparently 
has not been further adopted for screening assays. 
 
3.2.2. Y2H with cytosolic and membrane proteins 
 
The classic Y2H and the two alternative systems presented above require the translocation of the 
interacting proteins into the nucleus and are thus not suitable for membrane associated proteins, 
integral membrane proteins and many other soluble cytosolic proteins or proteins localized in other 
subcellular compartments. To circumvent these limitations, truncated versions of these proteins have 
been used for Y2H screens [69-71]. However, the use of such truncated proteins can lead to 
misfolding, and the problem remains that the nucleus is not the natural environment for most of these 
proteins. Such problems, probably leading to a high rate of false negatives in the past, would be 
circumvented by screening procedures where interacting proteins remain in their natural cellular 
compartment. Outside the nucleus, away from the transcription machinery, also the use of 
transactivating baits would no longer constitute a problem. 
The SOS- and the RAS recruitment systems (SRS and RRS) (Figure 2B) are bypassing the 
transcriptional readout by using the Ras signalling pathway, which is homologous between yeast and 
mammals. Ras has to be localized at the plasma membrane to undergo GDP-GTP exchange by guanyl 
exchange factors, Cdc25 in yeast or Son of sevenless (SOS) in mammals. This activated Ras then 
triggers downstream signalling. For the Y2H systems described here, a Cdc25-2 temperature sensitive 
yeast strain is used which is unable to grow at a higher temperature (36°C) because Cdc25-2 becomes 
inactive and fails to activate Ras signalling. The temperature-sensitive phenotype can then be rescued 
by alternative activation of Ras in the Y2H setup. 
In the SOS recruitment system (Figure 2B: SRS Y2H), a soluble protein X is fused to mammalian 
SOS. If the SOS-X fusion interacts with a prey localized in the membrane (e.g. via myristoylation), 
SOS stimulates guanyl exchange on yeast Ras (yRas) and promotes downstream signalling [51].  
In the Ras recruitment system (Figure 2B: RRS Y2H), the soluble protein X is directly fused to 
constitutively active mammalian Ras (mRas). Already active, this Ras only requires membrane 
location, bypassing the activity of Ras guanyl exchange factors (Cdc25 or SOS). The mRas-X fusion is 
recruited to the membrane by interaction with a membrane associated prey [57].  Int. J. Mol. Sci. 2009, 10                 
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Both SRS and RRS allow the analysis of interactions between soluble baits and soluble or 
membrane preys. Specifically for the use of membrane localized baits, the reverse Ras recruitment 
system (Figure 2B: rRRS Y2H) has been developed. Conversely to the RRS, the prey is the Ras fusion 
protein, and the bait is membrane-anchored or itself a membrane protein [63]. Although the rRRs has 
been used for screening procedures [63], it has an important disadvantage. Preys containing membrane 
proteins are self-activating, since they localize Ras to the membrane even without bait-prey 
interaction. These false positive membrane proteins have to be eliminated by additional selection steps, 
rendering the method more laborious. Exclusion of membrane and membrane-associated proteins also 
represents serious limitation as compared to other more recent Y2H techniques. 
The G-protein fusion system (Figure 2C) allows, similar to the rRRS, to study the interaction 
between integral membrane bait and a soluble prey. The latter is a fusion protein with the γ-subunit of 
a heterotrimeric G-protein. If the prey interacts with the membrane-located bait, it will sequester G-
protein  β-subunits, thus disrupting formation of heterotrimeric G-protein complex and subsequent 
downstream signalling [58]. The method has been used to identify neuronal Sec1 mutants unable to 
bind syntaxin1, a member of the SNARE complex [58]. Similar as with the RTA Y2H system (see 
above, Figure 2A), the authors suggest that G-protein Y2H may identify drugs disrupting protein-
protein interactions. Both systems report disrupted interaction by a gain of signal which is easier to 
detect in a library screen as compared to a loss of signal. 
The Split-ubiquitin system (Figure 2D) was designed by Johnsson and Varshavsky in 1994 [53] to 
allow detection of protein-protein interactions occurring between cytosolic proteins; it was later 
extended to membrane proteins. Ubiquitin is a small protein important for the turnover of cellular 
proteins. Proteins are labelled for proteasomal degradation by covalently attaching a poly-ubiquitin 
chain. This chain is then cleaved off prior to protein degradation by ubiquitin specific proteases (USP). 
The split ubiquitin Y2H technique is based on separation of ubiquitin into two independent fragments. 
It has been shown that ubiquitin can be split into an N-terminal (Nub) and a C-terminal half (Cub) and 
that these two parts retain a basic affinity for each other, thus allowing spontaneous reassembly of 
quasi-native ubiquitin. This spontaneous reassociation of Nub and Cub is abolished by point mutations 
(I13G or I13A) in Nub (NubG, NubA) [53]. In these mutants, efficient association is only observed if 
the two moieties are brought into close proximity by interaction of two proteins fused to NubG/A and 
Cub respectively. Reconstituted split-ubiquitin is recognized by USPs, which then cleave off any 
reporter protein fused to the C-terminal end of Cub. The original system used dihydrofolate reductase 
as reporter protein, whose release was detected by SDS-PAGE [53]. However, this readout was not 
convenient, since it needed immunoprecipitation and electrophoretic separation.  
Looking for a more direct readout, Ura3p protein has been used as reporter (Figure  2D: Split 
ubiquitin Y2H) [72]. Ura3p is an orotidine 5-phosphate decarboxylase (ODCase), an enzyme involved 
in the synthesis of pyrimidine ribonucleotides. ODCase activity leads to uracil auxotrophy and 
sensitivity to 5-fluoroorotic acid (5-FOA), because the latter is converted into the toxic compound 5-
fluorouracil, causing cell death. As Y2H reporter, a variant of Ura3p is used, rUra3p, which is N-
terminally modified for rapid degradation according to the N-end rule [73]. Interaction between bait 
and prey leads to ubiquitin reconstitution and subsequent cleavage of rUra3p, resulting in rapid 
degradation of rUra3p, inability to grow on minimal medium without uracil, and resistance to 5-FOA. Int. J. Mol. Sci. 2009, 10                 
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This system is not based on a transcriptional readout and can therefore be applied to nuclear, 
cytoplasmic and membrane proteins [74-76].  
In the membrane transactivator split-ubiqitin (MbY2H) system, an artificial transcription factor 
(LexA-VP16) has been used as a cleavable reporter protein to analyse interactions between membrane 
proteins of the endoplasmic reticulum (ER) (Figure 2D: MbY2H) [55]. Once ubiquitin is reassembled, 
LexA-VP16 is released to the nucleus, where it activates reporter gene transcription (i.e. HIS3, LacZ). 
Such a transcriptional readout leads to an amplification of the response following protein interactions 
and offers more sensitivity, more convenient for transient interactions. This system was successfully 
used to detect interactions involving different kinds of membrane proteins [56]. Split-ubiquitin based 
systems have become quite popular and have been successfully applied for cDNA library screens [77-
81] and large scale matrix approaches [82].  
Recently, an adaptation of the MbY2H system to screen cytosolic proteins has been published 
(Figure 2D: CytoY2H) [66]. Here, the bait construct contains both Cub and the transcription factor and 
is anchored to the ER membrane thanks to a fusion to the ER membrane protein Ost4p. This allows 
screening for interaction partners of a soluble protein among membrane and/or soluble proteins, as 
well as for proteins that are transcriptional activators or otherwise self-activating in nuclear Y2H. 
Other Split-protein sensors (Figure 2E)  have been developed, inspired by the split-ubiquitin 
system. While the cytosolic Y2H methods presented above are based on indirect readout that requires 
activation of signalling pathways or transcription, split-protein sensors can in principle also directly 
report their reconstitution. In 2004, Tafelmeyer et al. presented a combinatorial approach to generate 
split-protein sensors [65]. They used an enzyme in yeast tryptophan biosynthesis, N-(5-
phosphoribosyl)-anthranilate isomerase (Trp1p), to perform activity selections of different 
combinations of fragment pairs. They identified C-terminal (CTrp) and N-terminal (NTrp) fragments 
which reconstitute a quasi-native Trp1p only when fused to two interacting proteins that bring the 
CTrp and NTrp domains into close proximity. Thus, interacting fragments lead to Trp1p reconstitution 
and allow trp1 deficient yeast strains to grow on medium lacking tryptophan (Figure  2E: 
SplitTrpY2H). This system has several advantages. The readout is direct and permutation-independent, 
i.e. independent of whether CTrp or NTrp were used for bait constructs. It is universally applicable to 
all types of proteins, because the interaction readout is entirely independent of cellular localization.   
Recently, split enhanced green fluorescent protein has been used to monitor protein-protein 
interactions in yeast by confocal microscopy [53]. A variety of other split-protein sensors has been 
applied in eukaryotic cells (e.g. dihydrofolate reductase [54], β-galactosidase [55], β-lactamase [56]), 
but has not yet been used in Y2H screening. 
 
3.2.3. Yeast two-hybrid with extracellular and transmembrane proteins 
 
All Y2H systems presented so far detect interactions in the reducing intracellular environment, 
which is not necessarily ideal for extracellular proteins. However, interactions in the extracellular 
space, like between receptors and ligands or between antibodies and antigens, participate in a 
multitude of physiological processes, and their study is of particular interest for a better understanding 
of numerous pathologies.  Int. J. Mol. Sci. 2009, 10                 
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The SCINEX-P (screening for interactions between extracellular proteins) system (Figure 2F) 
published by Urech et al. in 2003 allows the analysis of protein-protein interactions in the oxidizing 
environment of the ER [64]. This system exploits the signalling of the yeast unfolded protein response 
(UPR). Accumulation of incorrectly folded proteins in the ER induces dimerization of the yeast ER 
type I transmembrane protein (Ire1p), which induces production of transcriptional activator Hac1p that 
will activate transcription of chaperons. In the SCINEX-P system, proteins of interest are fused to 
mutated Ire1p proteins, one lacking its luminal, N-terminal oligomerization domain (ΔIre1p). The 
interaction between two hybrid proteins then reconstitutes Ire1p dimerization and thus activates UPR 
downstream signalling. To monitor protein interactions, the Hac1p UPR element is introduced into the 
promoter of reporter genes. This Y2H system was successfully used to analyze the interaction between 
the protein disulfide isomerase ERp57 and Calnexin, both involved in protein folding in the ER [83], 
as well as known interactions between antigens and antibodies [64]. 
3.3. Dealing with doubt: Limitations of Y2H systems and methods for its validation 
Its relative methodical simplicity, its diversity, and its high-throughput capacity make the Y2H 
system the most popular analytic and screening method for interactomics. Nevertheless, all Y2H 
methods face the problem of false negatives and false positives.  
False negatives in Y2H are protein-protein interactions which cannot be detected due to limitations 
of the screening method. In the classic Y2H, for example, protein interactions involving membrane 
proteins are mostly undetectable. Thus, the Y2H strategy has to be chosen carefully, depending on the 
cellular sub-proteome of interest. Further, the interaction between the two proteins assayed in Y2H is 
often not symmetric (permutation-independent), meaning it depends on whether a given protein is used 
for fusion in the bait or the prey construct. The fused yeast reporter proteins or anchors may cause 
steric hindrance that impedes interaction, thus causing false negatives. Another reason for false 
negatives can be different or lacking post-translational protein modifications in the yeast system when 
analyzing interactions between proteins of higher eukaryotes. In this case, the modifying enzyme may 
be coexpressed in yeast together with bait and prey. This possibility has been used with success to 
identify tyrosine-phosphorylation dependent interactions [84]. Very transient interactions may also 
escape detection, as e.g. in case of substrate interactions of protein tyrosine phosphatase. Here, 
substrate-trap mutants have been used lacking phosphatase activity but retaining their affinity for the 
substrates to identify protein substrates of the phosphatase [85]. The expression of baits fused to their 
cognate modifying enzyme has been successfully used to identify acetylation dependent interactions 
with histones and interactions dependent on phosphorylation of the carboxy-terminal domain of RNA 
polymerase II [86]. The lack of more complex modifications, like complex glycosylation, appears to be 
more difficult to overcome. A humanized yeast strain has already been used to produce human 
glycosylated proteins in yeast Pichia pastoris [87], but it has so far not been used in Y2H.  
False negatives mainly cause problems in reproducibility of Y2H screens. Two independent large-
scale Y2H screens using the same Y2H method showed less than 30% overlap in the identified 
interactions and only 12,5% of known interactions were found in each of both [19]. These 
discrepancies may arise from a difference in selection stringency or a difference in the cDNA library 
used. Thus, false negatives represent a real limitation of the Y2H system in representing an entire Int. J. Mol. Sci. 2009, 10                 
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protein interaction network. However, each screening system has to deal with false negatives. For 
example, MS of purified protein complexes reveals only few interactions involving transmembrane 
proteins due to their difficult purification [88]. AP/MS was also shown to be biased towards highly 
abundant proteins, whereas protein abundance appears not to influence Y2H [88]. While purification 
of protein complexes has to deal with mixtures of proteins showing very different abundance, 
depending on the used cell type, such differences are avoided in Y2H by overexpression of interacting 
proteins at similar levels. However, protein overexpression can provoke other artefacts such as   
false positives. 
False positives in Y2H are physical interactions detected in the screening in yeast which are not 
reproducible in an independent system. They are of diverse origin and often depend on the Y2H 
system used. Among possible reasons for false positive interactions in yeast may be a high expression 
level of bait and prey and their localization in a compartment which does not correspond to their 
natural cellular environment. Another source of false positives is interaction of prey with the reporter 
proteins (e.g. LexA in the classic Y2H) or the membrane anchors (e.g. Ost4p in the cytoY2H) fused to 
the bait. Proteins which allow yeast to overcome nutritional selection when overexpressed are also 
often scored as false positives. Finally, proteins that are known to be “sticky” or that are not correctly 
folded can show unspecific interactions. In general, for each Y2H system, a list of recurrent false 
positives can be established. A list created by Golemis and co-workers for the classic Y2H can be 
found at http://www.fccc.edu/research/labs/golemis/InteractionTrapInWork.html.  
Despite these limitations, the Y2H system remains a powerful tool for large-scale screening in 
interactomics. The comparative assessment of high-throughput screening methods by von Mehring et 
al. [88] revealed that Y2H has a lower coverage of the protein interaction network than the purification 
of protein complexes coupled to MS. But these authors only considered the classic Y2H, while the 
above presented diversity of Y2H systems may increase coverage considerably. 
To evaluate the quality of a generated interaction data set, coverage and accuracy need to be 
considered together. In fact, a large interaction network cannot be a solid base for systems biology if 
confidence in the data is low. In a quantitative comparison of interaction data sets, von Mehring 
estimated the accuracy of a classic high-throughput Y2H screen to be less than 10%. Thus, the 
question remains how to increase accuracy of Y2H interaction data sets.   
As mentioned before, there are two different screening approaches: the targeted library screening 
approach and the global matrix screening approach. To increase accuracy of a library screen, a bait-
dependency test can be performed [66,94]. In this case, the previously identified preys are tested for 
interaction with unrelated baits. Preys interacting with others than the screening bait will be classified 
as false positives. This test helps to eliminate false positives resulting from non-specific interactions 
with the bait or other “sticky” interactions overcoming nutritional selection, but it cannot eliminate 
physical interactions, artificially occurring in the Y2H system without physiological meaning. For this 
reason, binary interactions detected in Y2H are nowadays published only if they are validated by other 
methods [80,89-91,93]. Different validation methods that can be used are listed in Table 2. Int. J. Mol. Sci. 2009, 10                 
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Table 2. Overview of different validation methods. 
Method  Type  Description 
Pull-down assay 
 [89-91]  in vitro 
Tagged bait (mostly expressed in E.coli) is immobilized on a resin and subsequently 
“pulls down” target protein (prey) from lysates (of eukaryotic cells or of E.coli 
expressing proteins of interest). After washing steps, prey is detected by SDS-
PAGE/immunoblot or MS. 
Coimmunoprecipitation 
 [80,89,90,92]  ex vivo  A specific antibody is used to precipitate the bait from cell lysates (see above). After 
washing steps, coimmunoprecipitated prey is detected as above. 
Surface plasmon resonance 
(Biacore) [93]  in vitro 
Bait immobilized on the surface of a sensor chip is probed by injection of prey onto 
the surface. Protein interaction is detected online via a biophysical principle (using 
the change in refractive index at the sensor surface in case of protein interaction). 
Protein is eluted and analyzed by MS. 
In situ hybridization  
[90]  in situ 
Hybridization of a labelled complementary DNA or RNA strand (i.e. probe) to a 
specific DNA or RNA sequence in a tissue section. Visualizes expression of specific 
genes to evaluate potential coexpression of proteins of interest in the same cell of a 
given tissue. 
Immunohistochemistry, immuno- 
cytochemistry [80,89,90]  in situ 
Proteins in fixed cells or tissue sections are detected by immune-labelling with 
fluorescently tagged antibodies, e.g. using confocal microscopy. Visualizes 
coexpression of proteins of interest in the same cell and potential subcellular 
colocalization.  
Fluorescent detection in live cells 
[91]  in vivo 
Proteins in living cells are detected with fluorescently tagged antibodies as above 
(using permeabilized cells) or after expression of fluorescently tagged protein 
variants. Visualizes colocalization of proteins of interest. 
Fluorescence resonance energy 
transfer (FRET) [80]  in vivo 
Bait and prey are fused to two different fluorescent tags with overlapping 
emission/excitation spectra. If both proteins are in close proximity, excitation of the 
first fluorophore (donor) leads to energy transfer to the second fluorophore 
(acceptor). Acceptor fluorescence can be observed in vitro (fluorimeter) or in living 
cells (confocal microscopy). 
Bioluminescencer resonance 
energy transfer (BRET) [92]  in vivo 
Similar to FRET (see above), but with bait fused to bioluminescent luciferase, thus 
avoiding the external excitation step susceptible to generate background. Detection 
as with FRET. 
 
It is advisable to use more than one method to validate an identified protein-protein interaction, 
preferentially coupling biochemical methods (pull down assay, immunoprecipitation, Biacore surface 
plasmon resonance) with in vivo/in situ methods (colocalization, immunohistochemistry, in situ 
hybridization). The former methods allow the study of physical protein interactions, but pull-down 
assays require a certain stability of the protein complex or, in case of Biacore, even need purified 
interaction partners. It may be also difficult to validate transient protein interactions or protein 
interactions with transmembrane proteins in these assays. The in vivo/in situ methods allow insight 
into possible coexpression and colocalization of the two proteins involved, but generally do not 
provide conclusive evidence for direct interaction. However, an advantage of in situ hybridization 
would be its adaptability for high-throughput. The FRET method has been developed to go beyond 
protein colocalization in vivo to study the spatio-temporal occurrence of the interaction and its 
physiological significance. FRET can only occur when the distance separating the two different 
fluorophores is in the low nm-range, a condition that occurs if fluorophores are coupled to two directly 
interacting proteins [95]. However, many of these methods are relatively labor intensive and can only 
be applied to a small number of interactions detected in a larger screen. 
Validation of results from high-throughput matrix studies is much more difficult to achieve. Using 
the mentioned validation methods would be experimentally extremely difficult. Given that both Int. J. Mol. Sci. 2009, 10                 
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interaction partners are randomly selected, the large amount of generated interaction data would 
already render a bait dependency test impossible. To handle the problem of false positives in such 
large-scale approaches, help is coming from computational biology. Confidence scores can evaluate 
the biological significance and probability of a given interaction. One possibility is to relate screening 
results to known data like RNA expression levels (expression profile reliability (EPR) index), or 
interaction networks of protein paralogues (paraloguous verification method (PVM)) [96]. Another 
score was calculated by combining data on sequence homology, known interacting Pfam domains and 
Gene Ontology annotations [97]. Even if these methods allow creation of higher confidence scores, 
they are limited by the number of existing data from other screens and experiments. Another 
possibility is thus the creation of a statistical model only based on screen data and topological criteria 
[98]. These scores will not replace experimental validation of detected interactions, but may provide a 
tool to select proteins for further experiments. 
 
4. Further Confirmation: Protein-Protein Interactions within a Biological System 
Once a protein-protein interaction has been identified and validated, the physiological function of a 
given interaction remains to be established in a biological system. The main questions in this respect 
are: (i) Where and when in the system the interaction does occur? (ii) Which parameters influence the 
interaction? (iii) What is the effect of the interaction? To answer these questions, the main strategy 
relies on varying different system parameters that mainly affects the proteins of interest. Combination 
of a panel of complementary methods is generally able to unveil the physiological significance of an 
interaction identified in a targeted approach. 
Colocalization experiments in cell culture under different conditions can give information about the 
spatiotemporal dynamics of the protein-protein interactions. For example, choosing different time 
points during the cell-cycle may reveal transient colocalizations. In the case of the reported interaction 
between brain type creatine kinase (BCK) and the cis-Golgi matrix protein (GM130), a transient 
colocalization during early prophase was observed [91]. The authors suggest that BCK would facilitate 
GM130 phosphorylation by ATP-requiring protein kinases and thus play a role in initial fragmentation 
of the Golgi apparatus prior to cell division. Many other endogenous or external parameters 
influencing protein-protein interaction can be varied, including activation of signalling cascades or 
changes in the cellular environment. To analyse the impact of given protein-protein interactions on the 
cellular phenotype, the interaction may be either disturbed, e.g. by RNA silencing of one interaction 
partner,  or favoured by addition or overexpression of one protein partner. More specifically, the 
interaction domains of both interaction partners can be mapped to inhibit the interaction in vivo by 
expressing interaction-deficient mutant proteins or using inhibitory peptides.  
These experiments can be carried out for defined interactions of a small number of proteins, but 
again it would be quite difficult to transfer them to the large interaction network generated by global 
screens. So far, interactome approaches concentrate on a characterization of the nodes in the 
interaction network, which may be the major determinants of a phenotype. 
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5. Conclusions 
Since systems biology aims at a complete representation of cellular complexity, thus avoiding any 
reductionism, the applied experimental strategies have to provide non-biased, complete data sets. In 
this context, the yeast two-hybrid technologies presented here are a starting point rather than a 
complete solution to the elucidation of interaction networks. However, Y2H has demonstrated its 
power by its methodological diversity and technical simplicity to rapidly generate a large amount of 
reliable protein-protein interaction data. More recent Y2H technologies, in particular those based on 
split proteins, allow to probe protein-protein interactions in their native cellular compartment and to 
access almost the entire cellular proteome. Y2H is rather complementary in respect to emerging 
AP/MS techniques, since it identifies direct interactions and also detects interaction of lower affinity 
that are rather transient. 
Developing high throughput approaches at the cellular level and further progress in bioinformatics 
will be necessary to make interactomics a fully integral part of a systems biology approach. Major 
efforts will be necessary for the challenge of modelling the large and dynamic interaction network of a 
cell. Only a combination of different approaches (e.g. Y2H, MS, bioinformatics) will eventually lead 
to an accurate description of large interaction networks. 
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